國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Identification of biomarkers, new tr...

Guest, Paul C.

Identification of biomarkers, new treatments, and vaccines for COVID-19

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Identification of biomarkers, new treatments, and vaccines for COVID-19edited by Paul C. Guest.
其他作者:	Guest, Paul C.
出版者:	Cham :Springer International Publishing :2021.
面頁冊數:	ix, 234 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Biochemical markers.
電子資源:	https://doi.org/10.1007/978-3-030-71697-4
ISBN:	9783030716974$q(electronic bk.)

Identification of biomarkers, new treatments, and vaccines for COVID-19
Identification of biomarkers, new treatments, and vaccines for COVID-19[electronic resource] /edited by Paul C. Guest. - Cham :Springer International Publishing :2021. - ix, 234 p. :ill., digital ;24 cm. - Proteomics, metabolomics, interactomics and systems biology,v.13272730-6216 ;. - Proteomics, metabolomics, interactomics and systems biology ;1118..

1. Genetic Aspects and Immune Responses in Covid-19: Important Organ Involvement -- 2. Prevalence of COVID-19 and the Continued Citizen-based Control in Japan -- 3. COVID-19 Pandemicin Brazil: History, Characteristics, and Evolution -- 4. The Experiences of Recovered COVID-19 Patients in Baqiyatallah Hospital: A Qualitative Study -- 5. Age-specific Differences in the Severity of COVID-19 Between Children and Adults: Reality and Reasons -- 6. Sex differences and COVID-19 -- 7. Intestinal Microbiota in the Sars-Cov2 Infection: What is known? -- 8. SARS-CoV-2 Infection and the Kidneys: an Evolving Picture -- 9. Cutaneous Manifestations of COVID-19: Early Diagnosis and Prognostic Information -- 10. How do we Manage Breastfeeding during the COVID-19 Pandemic? -- 11. Deep Learning Analysis in Prediction of COVID-19 Infection Status using Chest CT Scan Features -- 12. Using Ozone Therapy as an Option for Treatment of COVID-19 Patients: A Scoping Review -- 13. COVID-19, Coenzyme Q10 and Selenium -- 14. Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19) -- 15. Cinnamon: A Promising Natural Product against COVID-19 -- 16. Curcumin and Piperine in COVID-19: a Promising Duo to the Rescue -- 17. Association of in-hospital use of statins, aspirin and renin-angiotensin-aldosterone inhibitors with mortality and ICU admission due to COVID-19A -- 18. The Worldwide Effort to Develop Vaccines for COVID-19.

The novel coronavirus 2019 (COVID-19) has caused a serious global pandemic in just one year. Nearly every country and territory in the world has been affected by the virus. The virulence and infection rate of the virus are profound, and has required extreme social distancing measures across the globe in order to prevent overwhelming the healthcare services and hospitals. COVID-19 appears to have the greatest effects on elderly individuals and those who have co-morbid diseases, such as diabetes and obesity. As the cases and death rate remain high, there are justified fears of this virus remaining for several months or years to come. To address this, a rapid and unprecedented worldwide mobilization effort has begun to identify effective treatments and develop vaccines. As these begin to be deployed and administered across the globe, many now feel the virus will be brought under control and lives will eventually return to normal. This new volume will increase readers' understanding of the ongoing COVID-19 pandemic through a series of chapters that address these concerns. Leading experts will discuss new treatment approaches, vaccine development, mental health aspects of the pandemic, and convey the results of survey studies. The book will be an excellent resource for researchers studying virology, metabolic diseases, respiratory disorders, and clinical scientists, physicians, drug companies, and healthcare services and workers.

ISBN: 9783030716974$q(electronic bk.)

Standard No.: 10.1007/978-3-030-71697-4doiSubjects--Topical Terms:

195446
Biochemical markers.

LC Class. No.: R853.B54

Dewey Class. No.: 610.28

Identification of biomarkers, new treatments, and vaccines for COVID-19
LDR:03987nmm a2200337 a 4500 001 605174
003 DE-He213
005 20210719091700.0
006 m d
007 cr nn 008maaau
008 211201s2021 sz s 0 eng d
020 $a 9783030716974$q(electronic bk.)
020 $a 9783030716967$q(paper)
024 7 $a 10.1007/978-3-030-71697-4 $2 doi
035 $a 978-3-030-71697-4
040 $a GP $c GP
041 0 $a eng
050 4 $a R853.B54
072 7 $a MMFM $2 bicssc
072 7 $a MED052000 $2 bisacsh
072 7 $a MKFM $2 thema
082 0 4 $a 610.28 $2 23
090 $a R853.B54 $b I19 2021
245 0 0 $a Identification of biomarkers, new treatments, and vaccines for COVID-19 $h [electronic resource] / $c edited by Paul C. Guest.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a ix, 234 p. : $b ill., digital ; $c 24 cm.
490 1 $a Proteomics, metabolomics, interactomics and systems biology, $x 2730-6216 ; $v v.1327
505 0 $a 1. Genetic Aspects and Immune Responses in Covid-19: Important Organ Involvement -- 2. Prevalence of COVID-19 and the Continued Citizen-based Control in Japan -- 3. COVID-19 Pandemicin Brazil: History, Characteristics, and Evolution -- 4. The Experiences of Recovered COVID-19 Patients in Baqiyatallah Hospital: A Qualitative Study -- 5. Age-specific Differences in the Severity of COVID-19 Between Children and Adults: Reality and Reasons -- 6. Sex differences and COVID-19 -- 7. Intestinal Microbiota in the Sars-Cov2 Infection: What is known? -- 8. SARS-CoV-2 Infection and the Kidneys: an Evolving Picture -- 9. Cutaneous Manifestations of COVID-19: Early Diagnosis and Prognostic Information -- 10. How do we Manage Breastfeeding during the COVID-19 Pandemic? -- 11. Deep Learning Analysis in Prediction of COVID-19 Infection Status using Chest CT Scan Features -- 12. Using Ozone Therapy as an Option for Treatment of COVID-19 Patients: A Scoping Review -- 13. COVID-19, Coenzyme Q10 and Selenium -- 14. Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19) -- 15. Cinnamon: A Promising Natural Product against COVID-19 -- 16. Curcumin and Piperine in COVID-19: a Promising Duo to the Rescue -- 17. Association of in-hospital use of statins, aspirin and renin-angiotensin-aldosterone inhibitors with mortality and ICU admission due to COVID-19A -- 18. The Worldwide Effort to Develop Vaccines for COVID-19.
520 $a The novel coronavirus 2019 (COVID-19) has caused a serious global pandemic in just one year. Nearly every country and territory in the world has been affected by the virus. The virulence and infection rate of the virus are profound, and has required extreme social distancing measures across the globe in order to prevent overwhelming the healthcare services and hospitals. COVID-19 appears to have the greatest effects on elderly individuals and those who have co-morbid diseases, such as diabetes and obesity. As the cases and death rate remain high, there are justified fears of this virus remaining for several months or years to come. To address this, a rapid and unprecedented worldwide mobilization effort has begun to identify effective treatments and develop vaccines. As these begin to be deployed and administered across the globe, many now feel the virus will be brought under control and lives will eventually return to normal. This new volume will increase readers' understanding of the ongoing COVID-19 pandemic through a series of chapters that address these concerns. Leading experts will discuss new treatment approaches, vaccine development, mental health aspects of the pandemic, and convey the results of survey studies. The book will be an excellent resource for researchers studying virology, metabolic diseases, respiratory disorders, and clinical scientists, physicians, drug companies, and healthcare services and workers.
650 0 $a Biochemical markers. $3 195446
650 0 $a COVID-19 (Disease) $3 877725
650 1 4 $a Virology. $3 196498
650 2 4 $a Biomedicine, general. $3 853300
650 2 4 $a Physiology. $3 192980
700 1 $a Guest, Paul C. $3 771821
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Proteomics, metabolomics, interactomics and systems biology ; $v 1118. $3 834894
856 4 0 $u https://doi.org/10.1007/978-3-030-71697-4
950 $a Biomedical and Life Sciences (SpringerNature-11642)